Pfizer Inc. (BMV:PFE)

Market Cap	2.75T
Revenue (ttm)	1.33T
Net Income (ttm)	167.35B
Shares Out	n/a
EPS (ttm)	29.42
PE Ratio	16.44
Forward PE	n/a
Dividend	31.96 (6.40%)
Ex-Dividend Date	Jan 24, 2025

Volume	2,908
Average Volume	14,950
Open	511.00
Previous Close	518.35
Day's Range	498.98 - 515.30
52-Week Range	429.00 - 597.50
Beta	0.54
RSI	38.95
Earnings Date	Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD